Clinical trial
A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by…
NCT00223899 · Vical, Industry · Completed
Key facts
| NCT number | NCT00223899 |
|---|---|
| Title | A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma |
| Official title | A Phase 1, Multi-Center, Open-Label, Dose-Escalation Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma |
| Lead sponsor | Vical, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Genetic |
| Interventions | VCL-IM01 (encoding IL-2) with Electroporation |
| Enrollment | 26 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 27, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: